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OUTPATIENT ANTIBIOTIC USE IN PRIMARY HEALTH CARE IN NIS 
REGION
Kodela B1, Velickovic-Radovanovic R2, Petrovic J2, Mitic R2, Aleksic G1
1Pharmaceutical Institution of Nis, Nis, Serbia; 2Clinical Centre, Nis, Serbia
OBJECTIVES: Monitoring of antibiotic prescribing promotes rational use of drugs, 
reduces costs and slows down the development of resistance. The purpose of this study 
was to evaluate the prescribing of antibiotics in PHC of Niš region, during 2005–2009 
and to identify the practice of drug overuse, under-use or inappropriate use. 
METHODS: The data on outpatient use of antibacterials for systemic use was 
obtained by retrospective study and expressed as the number of deﬁ ned daily doses 
per 1000 inhabitants per day (DDD), according to WHO anatomic therapeutic chemi-
cal classiﬁ cation and DDD measurement methodology. The City Pharmacy Depart-
ment provided automatic reports on antibiotics prescribed by physicians for certain 
diagnoses in the Nis region over the 2005–2009 period. RESULTS: In the same period, 
outpatient antibiotic use in Nis region increased by 9.02% (22.83/ 25.96 DID). The 
most commonly prescribed drugs were semi-synthetics penicillins (9.67/10.00 DDD) 
and macrolides (3.05 /4.90 DDD). The greatest increase in antibiotics prescriptions 
was noted in azithromycin (0.26/0.70 DID, by 164%). Out of the total number of 
antibiotics, 70.5% prescriptions were made for treatment of URIs. Pharingitis ac. (J02) 
was the most common indication for prescription of antimicrobial medicines 
(45.26%). Amoxicillin (33%) and cephalexin (35%) were most commonly prescribed 
antibiotics for this indication. The total number of antibiotics prescriptions was 
increased by 14% while the cost was increased by 28% compared to 2005. CONCLU-
SIONS: Outpatient antibiotics use in Niš is high compared to the majority of European 
countries, which indicates the need for additional educational programs and monitor-
ing of microbiological sensitivity in future. The received results will be the basis for 
further evaluation of the rationality of use of antibiotics in primary health care.
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COST EQUITY ANALYSIS OF MALARIA MANAGEMENT: A PILOT 
STUDY IN THE AFRICAN SETTING
Espinoza MA1, Grifﬁ n S1, Cookson R2
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OBJECTIVES: To study the equity efﬁ ciency trade-off between decisions made based 
on maximization of health beneﬁ ts averaged for the whole population and decisions 
made considering the distribution of beneﬁ ts across socio economic groups of the 
population. METHODS: Cost-equity analysis nested in a CEA where ten different 
strategies for the management of patients with suspected non-complicated malaria 
were compared, in the African setting. Access to health clinics, access to treatment 
and adherence to the treatment were considered to vary between socio economic 
groups. a further hypothetical therapeutic alternative associated with 100% adherence 
for all groups was incorporated. Probabilistic sensitivity analysis was performed to 
reﬂ ect the uncertainty around parameter values. Inequality in the distribution of 
beneﬁ ts was estimated for each strategy using Concentration Indices (CI). The oppor-
tunity cost was estimated comparing the most cost-effective alternative against the 
most cost-equitable strategy in terms of health beneﬁ ts forgone to achieve a certain 
number of equality units. RESULTS: The most equitable strategy was also the most 
efﬁ cient for thresholds between US$137 and US$375 per DALY averted. Differences 
in equity of DALY burden between strategies were small (range CI units: 0.061–0.096) 
meaning the opportunity cost of choosing the most equitable strategy for threshold 
values outside of that range were relatively high, e.g. at US$400/DALY averted the 
opportunity cost was 0.11 DALYs per percentage point reduction in the CI. CON-
CLUSIONS: Equity concerns can be incorporated in the economic evaluation offering 
an estimation of the trade-off between efﬁ ciency and equity. Collection of information 
about access, adherence, effectiveness and costs according to socioeconomic group is 
required, but also information on prevalence for appropriate calculation of CI.
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OBJECTIVES: Seasonal inﬂ uenza incurs a substantial clinical and economic burden 
in infants, children, and adolescents. The objectives of this literature review were to 
assess the reported incidence and complications of virologically-conﬁ rmed paediatric 
inﬂ uenza, and to evaluate the extent of health care utilization, absenteeism, direct 
health care costs, and societal costs in nine European countries: the United Kingdom, 
Germany, Italy, Spain, France, Sweden, the The Netherlands, Finland, and Austria. 
METHODS: A structured literature search (January 1970-March 2009) of PubMed, 
EMBASE, and the Cochrane Library was conducted. Data on inﬂ uenza burden in 
children (aged ≤15 years) were extracted from 43 publications. Of these, 13 articles 
presented data on virologically-conﬁ rmed inﬂ uenza. Pooled data from these 13 studies 
are presented. RESULTS: Data varied widely between countries. Median incidence of 
conﬁ rmed inﬂ uenza was 15.4% but ranged from 1.1 to 33.0% (n = 6 studies) in 
children aged ≤15 years. This wide range in incidence resulted from differences 
between studies in inﬂ uenza conﬁ rmation methods, age groups, and inﬂ uenza seasons. 
Complications due to inﬂ uenza were frequently reported (e.g., acute otitis media 
[range 0–40% [n = 7 studies]], pharyngitis [range 31–48% [n = 3 studies]]). In one 
study, a 3-fold increase in direct medical costs (c189–c206 vs. c59 [2004 costs]) was 
observed. In another study of children aged ≤1 year, hospitalization was reported to 
be the main driver of disease-related direct medical costs with hospitalization rates of 
about 20%. Of children with conﬁ rmed inﬂ uenza, 28–55% used antibiotics (n = 6 
studies) and 76–86% required antipyretics or symptomatic treatment (n = 5 studies). 
Conﬁ rmed inﬂ uenza in children was associated with 3–12 days’ absence from school/
daycare (n = 5 studies), and 1.3–6.3 days’ parental absence from work (n = 6 studies). 
CONCLUSIONS: The clinical and economic burden of virologically-conﬁ rmed pae-
diatric inﬂ uenza in Europe appears to be signiﬁ cant as revealed by incidence and 
associated morbidity and costs. This study was funded by MedImmune, LLC.
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BRAZILIAN STD/AIDS PROGRAMME: EXPENDITURE ON 
ANTIRETROVIRAL DRUGS AND EPIDEMIC INDICATORS DURING THE 
PERIOD 2004–2008
Aurea AP, Garcia LP, de Magalhaes LCG, dos Santos CF, de Almeida RF
Institute for Applied Economic Research, Brasilia, DF, Brazil
OBJECTIVES: The Brazilian STD/AIDS Programme stands out for ensuring universal 
and free access to antiretroviral drugs. We estimated the Federal expenditure on 
antiretroviral drugs of the Brazilian STD/AIDS Programme, during the period 2004–
2008, and compared it to epidemic indicators of the Brazilian population. METHODS: 
The expenditure on antiretroviral drugs comes from a data warehouse of the Ministry 
of Planning, Budget and Management that stores the information concerning any 
purchase made by the Brazilian Federal Government. The epidemiological indicators 
of AIDS are derived from the Brazilian STD/AIDS Programme, which combines data 
from different national information systems. RESULTS: The expenditure on antiret-
roviral drugs rose from US$144.416.113,57 in 2004, to US$333.050.295,64, in 2008. 
In Brazil, from January 2004 to June 2008, there were 148.852 cases of AIDS 
reported, which corresponds to an incidence rate of approximately 20 cases per 100 
thousand inhabitants. In the period from 2004 to 2007 there were 44.381 deaths due 
to AIDS in Brazil, representing a crude mortality ratio of about 6 deaths per 100 
thousand inhabitants. CONCLUSIONS: The use of antiretroviral drugs increases the 
survival of patients with HIV/AIDS and reduces the mortality rate. Despite the stability 
of AIDS incidence and mortality coefﬁ cients over the analyzed period, the expenditure 
increased, which can be due to an increase in coverage and range of drugs offered. As 
the resources are limited, it is important to understand the magnitude of the consump-
tion as well as the mechanisms of purchase in order to improve the supply of antiret-
roviral drugs.
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FACTORS INFLUENCING THE DECISION TO BE VACCINATED 
AGAINST H1N1 IN GREECE
Athanasakis K, Zavras D, Kyriopoulos J
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OBJECTIVES: In view of the 2009 emergence of Inﬂ uenza a (H1N1) and the declara-
tion of a phase 6 pandemic by WHO, Greece established a voluntary vaccination 
program for the entire country population. The aim of the present study was to 
investigate factors affecting individuals’ decision to participate. METHODS: We con-
ducted repeated weekly telephone surveys until a random sample of 12,639 house-
holds stratiﬁ ed according to place of residence (geographical area and level of 
urbanization) was formulated. The interviews were based on a strictly structured 
questionnaire designed for the purpose of the study. a logistic regression analysis was 
conducted in order to identify the factors that inﬂ uence individuals’ decision to be 
vaccinated against H1N1. The Hosmer–Lemeshow criterion was used to check the 
model’s goodness of ﬁ t. RESULTS: Higher levels of personal education (Odds Ratio: 
0.61) and income (OR: 0.42) were associated with a negative decision to participate 
to the vaccination program. However, when an interaction term between the two 
variables was used, individuals of both higher education and income were more likely 
to have participated in the program (OR: 1.26). On the contrary, increased levels of 
concern/fear for the H1N1 and increased conﬁ dence to the personal/family physician, 
both measured in a 5-point Likert scale, showed a positive relationship. The Hosmer–
Lemeshow goodness of ﬁ t test statistic was 0.98 suggesting satisfactory ﬁ t of the 
model. CONCLUSIONS: In Greece, a country where less than 5% of the total popula-
tion participated to the voluntary vaccination program against H1N1, socioeconomic 
status, as expressed through income and education, the role of the family physician 
and the personal attitude towards H1N1 were important factors for a positive deci-
sion. In the case of similar future efforts, these variables should be taken into account, 
in order to facilitate focused interventions.
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OBJECTIVES: The objective of this study was to determine factors affecting the 
population’s decision to get vaccinated against the inﬂ uenza H1N1 virus. METHODS: 
Data for this study was obtained from a Panhellenic survey, organized by the National 
School of Public Health of Greece. The sample (n = 12,639) was drawn from strata 
of various degrees of urbanization and geographical region. The primary outcome of 
the survey was the intent to get vaccinated for H1N1; logistic regression was used to 
